Cartesian Therapeutics Inc (RNAC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 38,913 | 26,004 | 110,777 | 85,077 | 16,597 |
| Gross Profit | 38,913 | 26,004 | 110,777 | 85,077 | 16,597 |
| Operating Expenses | 82,810 | 112,420 | 96,239 | 89,674 | 73,418 |
| Operating Income | -43,897 | -86,416 | 14,538 | -4,597 | -56,821 |
| Interest Expense | 0 | 2,833 | 3,031 | 2,844 | 1,556 |
| Other Income | -33,240 | -149,461 | 23,263 | -2,280 | -10,499 |
| Pre-tax Income | -77,137 | -238,710 | 34,770 | -9,721 | -68,876 |
| Income Tax | 287 | -19,000 | -609 | 15,966 | N/A |
| Net Income Continuous | -77,424 | -219,710 | 35,379 | -25,687 | -68,876 |
| Net Income | $-77,424 | $-219,710 | $35,379 | $-25,687 | $-68,876 |
| EPS Basic Total Ops | -4.48 | -49.76 | 7.21 | -6.61 | -20.42 |
| EPS Basic Continuous Ops | -4.48 | -42.49 | 7.34 | -6.75 | -20.44 |
| EPS Diluted Total Ops | -4.49 | -49.76 | 3.00 | -6.61 | -20.42 |
| EPS Diluted Continuous Ops | -4.46 | -42.49 | 7.28 | -6.75 | -20.44 |
| EPS Diluted Before Non-Recurring Items | -4.49 | -10.21 | -2.40 | -6.01 | -18.32 |
| EBITDA(a) | $-42,746 | $-85,652 | $15,450 | $-3,288 | $-56,087 |